MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Home・Akciju saraksts・Microbot Medical Inc

Microbot Medical Inc

Slēgts

2.4 0.84

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.26

Max

2.4

Galvenie mērījumi
By Trading Economics
Ienākumi	113K -3.5M
Darbinieki	20
EBITDA	-561K -4.1M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+216.46% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 12. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-15M 154M
Iepriekšējā atvēršanas cena	1.56
Iepriekšējā slēgšanas cena	2.4

Tehniskais rādītājs

By Trading Central

Pārliecība

Neutral Evidence

2.52 / 2.57 Atbalsts un pretestība

Microbot Medical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 2. apr. 17:11 UTC

Galvenie tirgus virzītāji

Galvenie ziņu notikumi

Home Depot Shares Hit 52-Week Low as Iran War Threatens Housing Rebound

2026. g. 2. apr. 17:10 UTC

Galvenie ziņu notikumi

ECB's Next Move Likely a Rate Rise, But Timing Unclear Amid Iran War, Villeroy Says

2026. g. 3. apr. 00:00 UTC

Galvenie ziņu notikumi

How Insulated Is the U.S. Economy From the Iran War? -- WSJ

2026. g. 2. apr. 23:47 UTC

Tirgus saruna

Galvenie ziņu notikumi

Nikkei Might Rise After Thursday's Selloffs -- Market Talk

2026. g. 2. apr. 21:05 UTC

Iegādes, apvienošanās, pārņemšana

Starbucks: Under the Terms of the Agreement, Funds Managed by Boyu Cap Now Hold a 60% Stake in Starbucks China Retail Ops >SBUX

2026. g. 2. apr. 21:05 UTC

Iegādes, apvienošanās, pārņemšana

Starbucks: Retains 40% Ownership Interest and Continues to Own and License the Brand and Intellectual Property to JV >SBUX

2026. g. 2. apr. 21:05 UTC

Iegādes, apvienošanās, pārņemšana

Starbucks: Joint Venture Is Designed to Enhance Starbucks Ability to Expand Footprint, Deepen Local Relevance >SBUX

2026. g. 2. apr. 21:05 UTC

Iegādes, apvienošanās, pārņemšana

Starbucks and Boyu Cap: Finalize Joint Venture to Accelerate Long-Term Growth in China

2026. g. 2. apr. 21:01 UTC

Galvenie ziņu notikumi

Investors Waver after Trump Speech on Iran, Ending Two-Day Surge in Stocks -- WSJ

2026. g. 2. apr. 20:59 UTC

Iegādes, apvienošanās, pārņemšana

Starbucks and Boyu Capital Finalize China JV

2026. g. 2. apr. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 2. apr. 20:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 2. apr. 20:41 UTC

Peļņas

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2026. g. 2. apr. 20:32 UTC

Tirgus saruna

Higher Gas Prices Intensify K-Shaped Economy -- Market Talk

2026. g. 2. apr. 20:30 UTC

Iegādes, apvienošanās, pārņemšana

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2026. g. 2. apr. 20:09 UTC

Tirgus saruna

Eli Lilly On More Equal Footing With Rival With Weight-Loss Pill -- Market Talk

2026. g. 2. apr. 20:01 UTC

Iegādes, apvienošanās, pārņemšana

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2026. g. 2. apr. 19:46 UTC

Tirgus saruna

Is Oil the New GameStop? -- Market Talk

2026. g. 2. apr. 19:35 UTC

Tirgus saruna

U.S. Natural Gas Falls As Storage Injection Season Gets Under Way -- Market Talk

2026. g. 2. apr. 19:29 UTC

Iegādes, apvienošanās, pārņemšana

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2026. g. 2. apr. 19:24 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Futures Jump Ahead of Long Weekend -- Market Talk

2026. g. 2. apr. 19:20 UTC

Tirgus saruna

Nike Has Yet to Show That a Turnaround is on Horizon -- Market Talk

2026. g. 2. apr. 19:01 UTC

Iegādes, apvienošanās, pārņemšana

Union Pacific: ATDA Agreement to Guarantee Jobs for Life for Union Employees After Norfolk Southern Deal

2026. g. 2. apr. 19:00 UTC

Iegādes, apvienošanās, pārņemšana

Union Pacific: Agreement Reached With American Train Dispatchers Association

2026. g. 2. apr. 18:24 UTC

Iegādes, apvienošanās, pārņemšana

Globalstar Stock Rises on Amazon Deal Report. Why Apple Could Scuttle the Launch. -- Barrons.com

2026. g. 2. apr. 17:44 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Supply Squeeze Puts Refiners in a Quandary -- Market Talk

2026. g. 2. apr. 17:32 UTC

Galvenie ziņu notikumi

Amazon to Boost Fuel Surcharges on Third-Party Sellers as Costs Rise -- Barrons.com

2026. g. 2. apr. 17:26 UTC

Peļņas

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2026. g. 2. apr. 17:17 UTC

Tirgus saruna

Shares of Canadian Exports Heading to U.S. Continues to Slide -- Market Talk

2026. g. 2. apr. 17:09 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Holds Gains After Trump Speech Disappointed Market -- Market Talk

Salīdzinājums

Cenas izmaiņa

Microbot Medical Inc Prognoze

Cenas mērķis

By TipRanks

216.46% augšup

Prognoze 12 mēnešiem

Vidējais 7.5 USD 216.46%

Augstākais 12 USD

Zemākais 5 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

3 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

2.52 / 2.57Atbalsts un pretestība

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.